Wednesday, October 18, 2023
Avania, a distinguished global contract research organization (CRO) specializing in the realm of medical technology, has made an official announcement regarding its recent acquisitions. These strategic acquisitions, namely HULL ASSOCIATES LLC and Ironstone Product Development (IPD), have been strategically undertaken to address the evolving landscape of regulations and reimbursements within the dynamic field of medical technology (MedTech). The primary objective is to optimize operational efficiency and to provide comprehensive strategies and innovative project execution across a broad spectrum of product categories.
HULL ASSOCIATES LLC, headquartered in Boston, Massachusetts, is a well-regarded advisory firm with a strong focus on strategic market access and reimbursement. This firm boasts a dedicated team of experts in national market access who possess both the technical acumen and industry relationships necessary for achieving successful results. Their service portfolio encompasses a wide array of offerings, such as market access and reimbursement assessments, evidence planning, data analysis, health economics, price analysis, evaluation, and validation of clinical trial models, as well as post-marketing support within specific global markets for matters like coverage, coding, and payment.
The incorporation of these entities significantly bolsters and broadens Avania's operational capabilities, solidifying its position as a provider of highly personalized, comprehensive solutions to its clients. This move reaffirms Avania's status as a leader within the MedTech CRO sector and the preferred partner throughout the lifecycle of its clients' projects.